Kalaris Therapeutics, Inc. reported that on March 9, 2026, it released an updated corporate presentation for upcoming investor meetings which includes clinical trial timelines and cash guidance.
AI Assistant
KALARIS THERAPEUTICS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.